Chantix Settlement: $44M Refund Claims, Deadline 9/14/26

At a glance

Status

Closing soon

Defendant

Pfizer, Inc.

Settlement fund

$44,000,000

Claim deadline

September 14, 2026

No-proof cash option

Yes — Consumer class payments capped at 20% of the Available Settlement Fund, paid pro rata; documentation recommended but not strictly required. or up to Each consumer's claim not to exceed the total amount paid for Chantix; third-party payors reimbursed pro rata by documented payments.

Estimated payout

Consumer class payments capped at 20% of the Available Settlement Fund, paid pro rata; documentation recommended but not strictly required. or up to Each consumer's claim not to exceed the total amount paid for Chantix; third-party payors reimbursed pro rata by documented payments.

Administrator

A.B. Data, Ltd.

Official site

www.chantixsettlement.com

Court

United States District Court for the Southern District of New York

Case number

22-MD-3050 (KPF) (In re Chantix (Varenicline) Mktg., Sales Pracs. & Prods. Liab. Litig. (No. II)), No. 22-MD-3050 (KPF)

Last verified September 9, 2026

Key dates

Milestone	Date	What it means
Claim deadline	September 14, 2026	Last day to file for a payment
Opt-out (exclusion) deadline	September 14, 2026	Last day to leave the settlement and keep the right to sue
Objection deadline	September 14, 2026	Last day to object to the terms
Final approval hearing	October 13, 2026	When the judge decides whether to approve the settlement
Expected payout	Not yet scheduled	Payments are not sent until after final approval and any appeals

Where to file

Chantix (Varenicline) Nitrosamine Economic-Loss Settlement is administered by A.B. Data, Ltd.. The only place to file is the official settlement website:

File at the official site

www.chantixsettlement.com

Filing is free. No legitimate settlement charges a fee to file a claim.

You cannot file on RecordingLaw.com. We are an independent publisher, not the settlement administrator, and we are not affiliated with any court, agency, or defendant.

As of July 2026, Pfizer's $44 million Chantix (varenicline) settlement is open for claims, and the deadline to file or exclude yourself is September 14, 2026. This is not a data breach case and it does not pay out for cancer or other physical harm. It is an economic-loss settlement: money back for what class members paid for Chantix tablets that Pfizer later recalled nationwide over a nitrosamine impurity. Here is what the case is about, who is covered, and how much you can realistically expect.

What the lawsuit is about

Chantix, known generically as varenicline, is a prescription drug Pfizer sells to help smokers quit. In September 2021, Pfizer expanded a recall already underway to cover all lots of Chantix 0.5 mg and 1 mg tablets sold in the United States, after testing found the tablets contained N-nitroso-varenicline, a nitrosamine impurity, at or above the FDA's acceptable intake limit. The FDA has said long-term exposure to that impurity carries a theoretical increased cancer risk, though it also said there was no immediate risk to patients taking the medication at the time.

This settlement grew out of that recall, but it is narrower than the recall itself. It resolves an economic-loss claim on behalf of people and health plans that paid for Chantix, the argument being that class members would not have paid what they did, or paid at all, had they known the tablets contained the impurity. The case is consolidated as In re Chantix (Varenicline) Marketing, Sales Practices and Products Liability Litigation (No. II), case number 22-MD-3050 (KPF), in the U.S. District Court for the Southern District of New York.

Where this stands right now

As of July 2026, the settlement has preliminary court approval and is open for claims. A final approval hearing is scheduled for October 13, 2026 at 3:00 p.m., where a judge will decide whether to approve the $44 million deal, rule on the attorneys' fee request, and consider any objections.

No payout date has been set yet. That is normal at this stage; funds in settlements like this one are not distributed until after final approval, and often not until any appeal period has run. If you file a claim now, expect to wait until after the October hearing, at minimum, before anything is paid.

The claim deadline, September 14, 2026, matters most right now if you have not filed. It is also the exclusion (opt-out) deadline, and the official settlement site lists that same September 14, 2026 date as the deadline to object to the settlement. If you want to object rather than opt out, follow the objection procedure described on the official Notice and FAQ page.

Who's actually in the class

You may be part of the class if you, or a health plan or other third-party payor on your behalf, paid any amount of money for a retail purchase of Chantix in the United States or its territories between September 29, 2015 and September 17, 2021. That is nearly six years of purchases, so the class is large: essentially anyone who filled a Chantix prescription at a US pharmacy in that window, whether they paid cash, a copay, or had an insurer or health plan pay on their behalf.

You do not need to have gotten sick to be part of this class, and you do not need to still have the pills or the packaging. Pharmacy receipts, prescription records, or insurance statements from that period will help support your claim, but are not strictly required.

This settlement pays for the purchase, not for health harm

It is worth being precise about what this money is for. This is an economic-loss settlement: it compensates class members for money spent on Chantix, not for a cancer diagnosis or any other physical injury. If you believe you were harmed medically by taking Chantix, that is a personal injury claim, a different legal track entirely, and this settlement and this page do not address or resolve it. Talk to a lawyer separately about that question; do not expect this claims process to cover it.

How much you can realistically expect

There is no flat, per-person check here. Total consumer payments are capped at 20% of the available settlement fund and paid pro rata, meaning the money set aside for consumers is divided among everyone who files a valid claim, based on what they say, or can show, they paid for Chantix, up to the amount each person actually spent. The remainder of the $44 million fund is set aside to reimburse third-party payors, such as insurers or pharmacy benefit plans, pro rata for documented amounts they paid.

The more people who file, the smaller each individual payment gets, because the fund itself does not grow. Nobody is promised a specific dollar figure going in, so treat any published maximum as a ceiling, not a typical outcome.

What you'll need to file

Consumer claims allow a no-proof option: you can submit a claim and self-certify how much you spent on Chantix without attaching a receipt. Documentation, such as a pharmacy printout or an insurance statement showing your Chantix purchases, is recommended because it can support a larger claim, but it is not strictly required for consumers. Even so, keep any purchase records you have. The Settlement Administrator may still request supporting documentation to verify a no-proof claim, and a claim can be denied if requested records are not provided within the time allowed. If you are filing as, or on behalf of, a third-party payor such as an insurer or health plan, expect the process to require documented proof of the amounts paid, since that portion of the fund is reimbursed pro rata based on documentation rather than self-certification.

How filing works

Claims and requests to be excluded from the class are both due September 14, 2026. File after that date and the administrator, A.B. Data, Ltd., cannot accept your claim. Filing a claim and excluding yourself are opposites, not two boxes on the same form. Exclude yourself and you keep your own right to sue Pfizer separately, but give up any payment from this fund. File a claim instead and you stay in the class, giving up that separate right to sue over the same economic-loss theory.

If you're not sure you bought Chantix in the window, or you find this page after the deadline

If you cannot remember exactly when you filled a Chantix prescription, check old pharmacy records or an insurance explanation-of-benefits history before assuming you are not covered. The class period runs almost six years, from September 2015 to September 2021, so a lot of former Chantix users are likely eligible without realizing it.

If you are reading this after September 14, 2026, the claims window for this settlement is closed, and filing is generally no longer possible outside limited circumstances the administrator controls. This matter did not involve a reported theft or exposure of personal data, so the credit-freeze and identity-monitoring steps that make sense after an actual data breach are not the concern here. Watch instead for anything claiming to reopen claims for a fee, or asking for your Social Security number or bank login to "process" a Chantix payment; the real administrator will never ask you to pay to file or to hand over banking credentials by phone or text.

For other open, currently verified settlements, see RecordingLaw's data breach and privacy settlement tracker.